Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Depomed Inc (NASDAQ:DEPO)

16.07
Delayed Data
As of Feb 11
 +0.60 / +3.88%
Today’s Change
13.27
Today|||52-Week Range
33.74
-11.36%
Year-to-Date
No recent news for Depomed Inc.

Today’s Trading

Previous close15.47
Today’s open15.15
Day’s range14.87 - 16.30
Volume1,629,742
Average volume (3 months)1,816,879
Market cap$935.6M
Dividend yield--
Data as of 3:59pm ET, 02/11/2016

Growth & Valuation

Earnings growth (last year)+173.33%
Earnings growth (this year)+207.13%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)+190.87%
P/E ratio21.0
Price/Sales2.74
Price/Book2.52

Competitors

 Today’s
change
Today’s
% change
BGNEBeiGene Ltd-2.78-10.34%
DNAIProNAi Therapeutics ...-0.30-4.56%
OASMOasmia Pharmaceutica...+0.23+6.20%
NEPTNeptune Technologies...-0.02-1.92%
Data as of 4:00pm ET, 02/11/2016

Financials

Next reporting dateMarch 3, 2016
EPS forecast (this quarter)$0.29
Annual revenue (last year)$390.4M
Annual profit (last year)$131.8M
Net profit margin33.75%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
James A. Schoeneck
CFO, Senior VP &
Head-Investor Relations
August J. Moretti
Corporate headquarters
Newark, California

Forecasts

Partner Offers